Fig. 5 | Scientific Reports

Fig. 5

From: Multicenter analysis of the Mycoplasma pneumoniae resurgence in China 2023–2024

Fig. 5

Clinical characteristics and treatment of patients infected with Mycoplasma pneumoniae subtypes P1-1 and P1-2. (A) Disease severity (outpatient, inpatient, or ICU admission) stratified by M. pneumoniae subtype (P1-1 vs. P1-2). (B) Hospital length of stay for hospitalized patients (inpatient) infected with P1-1 or P1-2 subtypes. (C) Antibiotic treatments administered, comparing drug resistance patterns and disease severity among all patients. Statistical significance was determined by chi-square test; a p-value < 0.05 was considered significant.

Back to article page